CVS Health Reports Third Quarter 2025 Results with Adjusted EPS Beat and Updated Guidance

Details

The company reported an Adjusted EPS of $1.60, which represents an increase of $0.51 compared to the prior year. CVS Health also updated its full-year 2025 guidance, reflecting performance in its Health Care Benefits and Pharmacy & Consumer Wellness segments, partially offset by a decrease in the Health Services segment. A $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit impacted the reported GAAP diluted loss per share of $3.13.

Items reported

About CVS Health Corporation

CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.